Form 8-K - Current report:
SEC Accession No. 0000950170-22-020105
Filing Date
2022-10-26
Accepted
2022-10-26 08:02:01
Documents
13
Period of Report
2022-10-26
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K eftr-20221026.htm   iXBRL 8-K 63776
  Complete submission text file 0000950170-22-020105.txt   222014

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eftr-20221026_lab.xml EX-101.LAB 18513
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eftr-20221026.xsd EX-101.SCH 3355
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eftr-20221026_pre.xml EX-101.PRE 14480
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eftr-20221026_def.xml EX-101.DEF 14425
7 EXTRACTED XBRL INSTANCE DOCUMENT eftr-20221026_htm.xml XML 6572
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

EIN.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39866 | Film No.: 221331140
SIC: 2834 Pharmaceutical Preparations